MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
TGF-?1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma	https://doi.org/10.1007/s00432-015-2028-9	2016	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Long non-coding RNA ZFAS1 regulates NOB1 expression through interacting with miR-646 and promotes tumorigenesis in osteosarcoma	https://doi.org/10.26355/eurrev_201904_17679	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1	https://doi.org/10.3892/ijo.2018.4275	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase	https://doi.org/10.3892/etm.2013.959	2013	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-?B signaling pathway	https://doi.org/10.26355/eurrev_201811_16380	2018	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-765 targets MTUS1 to promote the progression of osteosarcoma via mediating ERK/EMT pathway	https://doi.org/10.26355/eurrev_201906_18040	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells	https://doi.org/10.3892/etm.2014.1942	2014	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66	https://doi.org/10.1177/1533033819870209	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma	https://doi.org/10.1002/ijc.32368	2019	Cell line 15 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression	https://doi.org/10.1371/journal.pone.0114757	2014	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-196a expression in human and canine osteosarcomas: a comparative study	https://doi.org/10.1016/j.rvsc.2014.12.017	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene	https://doi.org/10.1186/s12935-016-0340-3	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively	https://doi.org/10.1007/s10585-016-9783-0	2016	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene	https://doi.org/10.18632/oncotarget.8546	2016	Cell line 6 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene	https://doi.org/10.1038/srep44218	2017	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene	https://doi.org/10.1186/s12885-016-3002-x	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1	https://doi.org/10.1002/cbin.10723	2017	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs	https://doi.org/10.1093/carcin/bgz130	2019	Cell line 6 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis	https://doi.org/10.1002/jcp.26923	2018	Cell line 4 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression	https://doi.org/10.3892/ol.2017.7364	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications